We are live on
!
Find out more
SRNE
Sorrento Therapeutics, Inc.
SRNE
SRNE
Delisted
SRNE was delisted on the 22nd of February, 2023.
85 hedge funds and large institutions have $52.1M invested in Sorrento Therapeutics, Inc. in 2019 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 31 increasing their positions, 18 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
72% more repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 18
18% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 11
11% more call options, than puts
Call options by funds: $901K | Put options by funds: $813K
2% more funds holding
Funds holding: 83 → 85 (+2)
31% less capital invested
Capital invested by funds: $75.2M → $52.1M (-$23M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
85
Holders Change
+2
Holders Change %
+2.41%
% of All Funds
1.86%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
13
Increased
31
Reduced
18
Closed
11
Calls
$901K
Puts
$813K
Net Calls
+$88K
Net Calls Change
-$334K
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$775K |
| 2 |
BlackRock
New York
|
+$676K |
| 3 |
Northern Trust
Chicago,
Illinois
|
+$338K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$239K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$237K |
